Exploring Emerging and Innovative Biomarkers for the Assessment and Monitoring of Cardiovascular Disease Risk and Treatment Efficacy in Patients
The current research examines the creation of biomarkers for measuring cardiovascular disease (CVD) risk and tracking therapy effectiveness. While current biomarkers like cholesterol levels and troponins are useful, developing and innovating new biomarkers gives fresh insights into CVD etiology and...
Saved in:
| Main Author: | Omar Elsaka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-03-01
|
| Series: | APIK Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ajim.ajim_45_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Precision medicine: biomarker testing for diagnosis and treatment of cardiovascular disease
by: Hendrianus Hendrianus, et al.
Published: (2025-02-01) -
Current Bioinformatics Tools in Precision Oncology
by: Tesfaye Wolde, et al.
Published: (2025-07-01) -
From Reactive to Proactive: Advances Leading the Paradigm Shift in Cholecystitis Management
by: Tamer A. Addissouky
Published: (2023-11-01) -
Introduction to the forensic research via omics markers in environmental health vulnerable areas (FROM) study
by: Jung-Yeon Kwon, et al.
Published: (2024-07-01) -
Precision medicine in diabetes prediction: Exploring a subgroup‐specific biomarker strategy for risk stratification
by: I‐Weng Yen, et al.
Published: (2025-01-01)